Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006501 · ClinicalTrials.gov registry record
Prognostic Significance of T Wave Alternans
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 549
- Enrollment target
NCT00006501 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 549 participants.
The verdict
NCT00006501 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 549 participants
- Enrollment target
Study Summary
To evaluate whether T Wave Alternans can predict ventricular arrhythmias and sudden cardiac death (SCD) in a prospective epidemiologic natural history study. The prospective epidemiologic pilot study included 550 patients that had left ventricular dysfunction and no history of sustained ventricular arrhythmias. The primary hypothesis tested was whether there was an increased risk of having an arrhythmic event when T Wave Alternans was present in the patient. The secondary aims included comparing risk due to T Wave Alternans between the ischemic patients and non-ischemic patients and assessing whether T Wave Alternans remained an independent predictor of risk upon adjustment for other known risk factors for arrhythmic events such as ejection fraction, ventricular ectopy, NSVT, average NN interval, and RR interval variability. The study approach was a standard epidemiologic surveillance technique. The subject population consisted of individuals with Class I to III heart failure who will underwent a TWA and Holter monitor test and then were followed for up to two years or until arrhythmic events occured.
Interventions
- PROCEDURE ECG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 549 participants |
| Start Date | 2003-01 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006501
The ClinicalTrials.gov registry entry for NCT00006501 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 549 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ECG is the first listed.
NCT00006501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006501 about?
NCT00006501 is a clinical study titled "Prognostic Significance of T Wave Alternans". To evaluate whether T Wave Alternans can predict ventricular arrhythmias and sudden cardiac death (SCD) in a prospective epidemiologic natural history study. The prospective epidemiologic pilot study included 550 patients that had left ventricular dysfunction and no history of sustained ventricular...
What is the current status of trial NCT00006501?
This trial is currently completed. The enrollment target is 549 participants. The study started on 2003-01. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00006501?
The interventions under investigation include: ECG (PROCEDURE).
Who is sponsoring clinical trial NCT00006501?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.